Company Filing History:
3 out of 6 
3 out of 6 Years Active: 2019-2022
Title: The Innovative Contributions of Chan-Jung Li in Pharmaceutical Formulations
Introduction:
Chan-Jung Li is an esteemed inventor based in Taipei, Taiwan, renowned for his significant contributions to the field of pharmaceutical formulations. With three patents to his name, he has demonstrated a commitment to advancing medical science through innovative solutions.
Latest Patents:
Li's most notable recent patents focus on the development of injectable, extended-release pharmaceutical formulations that utilize sebacoyl dinalbuphine ester. His inventions comprise a nalbuphine ester prodrug that is homogenously dissolved in a solution containing both a pharmaceutically acceptable oil and an oil-miscible retaining solvent. The manufacturing processes and medical applications of these formulations are cutting-edge. Furthermore, he provides methods for adjusting the duration of action of the formulations by varying the ratios of the components, showcasing his innovative approach to enhancing therapeutic efficacy.
Career Highlights:
Chan-Jung Li has significantly impacted the pharmaceutical industry, notably by working with Lumosa Therapeutics Co., Ltd. and Shanghai Lumosa Therapeutics Co., Ltd. His experience with these innovative companies has enabled him to thrive and contribute unique solutions to the medical field.
Collaborations:
Throughout his career, Li has collaborated with esteemed professionals such as David Chih-Kuang Chou and Jin-Ding Huang. These collaborations reflect his ability to work effectively within a team, driving progress in his area of expertise and establishing a network of expertise in pharmaceuticals.
Conclusion:
In summary, Chan-Jung Li's work exemplifies the spirit of innovation in the pharmaceutical industry. His recent patents, career achievements, and collaborations highlight his dedication to improving medical formulations that can have a lasting impact on patient care. Through his continued efforts, Li sets an example for future inventors looking to push the boundaries of what is possible in the field of pharmaceuticals.